Development
Molina Healthcare, Inc.
MOH
$296.88
$3.321.13%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 37.75% | 10.97% | 21.81% | 24.09% | 20.18% |
| Total Depreciation and Amortization | -7.38% | -1.63% | 12.73% | 29.90% | 35.56% |
| Total Amortization of Deferred Charges | 7.41% | 31.71% | 31.71% | 31.71% | 31.71% |
| Total Other Non-Cash Items | -66.01% | 174.49% | 136.11% | 128.30% | 138.68% |
| Change in Net Operating Assets | 170.09% | 59.04% | -87.66% | -95.01% | -136.63% |
| Cash from Operations | 115.01% | 35.27% | -19.23% | -30.72% | -63.52% |
| Capital Expenditure | 7.69% | 2.94% | -6.12% | -19.05% | -18.18% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 97.76% | 98.86% | -3.88% | -3.88% | -3.88% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.28% | 58.13% | 75.14% | 27.13% | 60.95% |
| Cash from Investing | 5.82% | 61.55% | 65.25% | 21.85% | 52.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 86.78% | -2.76% | -2.36% | -751.85% | -150.83% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -84.62% | -- | 328.57% | 293.75% | 168.42% |
| Cash from Financing | 86.85% | -2.95% | 9.16% | -709.43% | -140.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 287.77% | 1,046.43% | 294.30% | -172.90% | -261.84% |